An FDA 510(k) cleared device that measures pulse waveform and heart rate from a fingertip sensor. A fast chairside screen with an immediate report, built to run at every consultation. Not a substitute for a formal cardiac workup.
Max Pulse records a single thing, the pulse waveform at the fingertip, and reports what is measured and what the manufacturer derives from that trace. The clinician interprets the report. TITN positions it as a fast cardiovascular wellness screen at the consult, not a cardiac diagnosis and not a replacement for a formal workup.
The fingertip photoelectric plethysmograph trace, recorded from the left index finger. In our placements the capture typically runs one to three minutes. This waveform is what the cleared measurement captures, and everything else on the report is read out of it.
Heart rate comes from the same recording and sits inside the cleared measurement. Rhythm regularity is read from the beat-to-beat intervals in that waveform, so it is derived from the trace rather than separately cleared.
The manufacturer's derived output from the shape of the waveform. It is not part of the FDA-cleared indication, so TITN presents it as a manufacturer index the clinician weighs in context, never as a diagnosis.
FDA 510(k) K110374 (Medicore). The clearance, the verbatim intended use and how practices price it are under Clearance & coverage below.
One short screen, read differently depending on the practice. Each use here is an aid to your clinical judgment, captured the same way every visit so a rescreen compares against a real baseline instead of a fresh impression.
A pulse-wave snapshot taken at the consult, next to the exam and whatever formal workup follows. It opens the cardiovascular conversation on measured ground; it does not stand in for a cardiac diagnosis.
Cardiology page →A quick cardiovascular data point inside a diabetes or metabolic workup, captured at the same visit as the autonomic and vascular testing on TM-Flow.
Endocrinology page →A fast circulatory read inside a whole-person intake, sitting alongside the autonomic and metabolic work rather than replacing any of it.
Integrative page →A cardiovascular baseline at the first visit, tracked on the same protocol over years, so the patient is compared against their own history rather than a single number.
Integrative page →A screen the practice can offer at any visit, with an immediate report that gives the preventive conversation something measured to start from.
All diagnostics →When the screen surfaces something worth a closer look, the clinician has a documented reason to go wider on the same visit or to route the patient toward a formal cardiac workup.
TM-Flow page →The report is written to be read with the patient, which is what makes lifestyle guidance land: they see the same picture the clinician is describing, then see it again at the rescreen.
See a sample report →A trained tech or medical assistant runs it, not the physician. Consistent placement and a steady patient are what make the retest a real comparison.
The patient sits, rests, and places the left index finger in the photoelectric sensor. No prep, no gel, no needles.
The device records the fingertip pulse waveform and heart rate over a short, steady window. About one to three minutes, captured the same way each visit.
The system derives an arterial stiffness index from the waveform (the manufacturer's derived output, not the FDA-cleared indication) and assembles them into a structured, patient-friendly report.
The report is ready at point of care. The clinician interprets it with the patient in the room, and a BMTG read is available where a deeper interpretation helps.
Max Pulse runs fine on its own at point of care. When you want the cardiovascular picture interpreted alongside the rest of a patient's data, BMTG, TITN's sister service, adds the read so you stay in your specialty.
Max Pulse results can be reviewed alongside autonomic and vascular data from TM-Flow and the rest of the TITN line, then returned through TITN's HIPAA-compliant portal with our template visuals. For wellness, longevity, and integrative use, interpreted by a BMTG clinician or by your own team using our templates.
Max Pulse fits TITN's baseline-treat-retest methodology. Screen at intake, document the cardiovascular wellness picture, run your protocol, then rescreen so the change is on the page. BMTG can frame the before-and-after so the patient and the practice both see the trend.
Max Pulse records the fingertip pulse waveform by photoelectric plethysmography. The clinician interprets it. We hold the claims to the cleared indication and frame it for what it is: a fast cardiovascular wellness screen that opens the conversation, not a cardiac diagnosis.
K110374 · Max Pulse. Class II, photoelectric plethysmograph, regulation 21 CFR 870.2780. Cleared June 2011.
The questions clinics ask before they add a cardiovascular wellness screen.
Yes. Max Pulse is FDA 510(k) cleared under K110374 as a Class II photoelectric plethysmograph. The clearance covers noninvasive measurement of pulse waveform and heart rate at the left index finger in adults. It does not cover a diagnostic claim for any named cardiac condition, so TITN presents it as a cardiovascular wellness screen and nothing more.
Max Pulse records one thing: the fingertip pulse waveform, captured by photoelectric plethysmography from the left index finger. Heart rate comes from that same recording and sits inside the cleared measurement. Rhythm regularity is read from the beat-to-beat intervals. The arterial stiffness index is the manufacturer's derived output from the waveform shape, not part of the cleared indication.
A screening tool. Max Pulse is not a cardiac diagnostic and does not diagnose coronary artery disease, heart failure, or arrhythmia. It gives the clinician a fast, measured cardiovascular snapshot at the consult. An abnormal or borderline result is a reason to pursue the appropriate indicated workup, not a finding to treat as confirmatory on its own.
It does not replace ankle-brachial index testing for peripheral arterial disease, echocardiography, or a cardiac stress test. Max Pulse opens the cardiovascular conversation on measured ground; the formal workup still belongs to the indicated diagnostic study. TITN positions the screen as an entry point that helps surface which patients deserve a closer look, ordered when clinically indicated.
About one to three minutes at the chairside. The patient sits, rests, and places the left index finger in the photoelectric sensor. No prep, no gel, no needles. A trained technician or medical assistant runs it rather than the physician, and the structured report is ready at point of care so the clinician can review it with the patient in the room.
No. TITN offers Max Pulse as a cash-pay wellness screen, and no code is published for it. FDA clearance establishes that a device is safe and substantially equivalent for its stated use; it does not establish payer coverage. CMS's national coverage determination for plethysmography treats the photoelectric method as not providing reproducible blood-flow measurements, which is a separate question from clearance.
Because clearance and coverage answer different questions. A 510(k) clearance says the device is substantially equivalent to a predicate for its stated measurement. Coverage asks whether that measurement changes clinical outcomes reproducibly enough to pay for. CMS's plethysmography coverage determination and at least one commercial policy have reached a negative answer on the second question while the first stands.
Adults interested in a baseline pulse-wave snapshot as part of a wellness, preventive, longevity, or integrative visit. The device is cleared for patients age 18 and older weighing 100 pounds or more. It is not a substitute for indicated diagnostic workup in a patient with cardiac symptoms; those patients need the appropriate cardiac study, not a screen.
The limitations are those of any fingertip photoelectric sensor: poor perfusion, nail polish or pigment at the sensor site, and motion artifact can all affect the trace. Follow the device documentation rather than assuming a clean capture in every patient. Consistent placement and a rested, steady patient are what make a rescreen a true comparison against the earlier reading.
It is a patient-friendly entry point. A one-to-three-minute chairside capture produces an immediate, visual report that gives the preventive conversation something measured to start from, and the same protocol at every visit makes the rescreen a real comparison. It also pairs naturally with the autonomic and vascular testing on TM-Flow when the visit warrants going wider.
Book a 15-minute call. We will walk through the one-to-three-minute screen, what the report shows, and how practices price it, then bring the device to you if you want to see it run.
Book a call
Write to support@transitionitnow.com and Roberto or Weston answers personally ·
(213) 444-6123
Transition IT Now · Santa Monica, CA
Verified live August 27, 2026. Spot a broken or outdated link? Email support@transitionitnow.com.